WALTHAM, Mass. and BEVERLY HILLS, Calif., March 30, 2021 /PRNewswire/ — CorEvitas and The Guthy-Jackson Charitable Foundation (GJCF) are excited to announce plans for launching the SPHERES (Synergy of Prospective Health & Experimental Research…
Learn about the four main advocacy groups in NMOSD, and their incredible origin stories. Click here to view the full article.
Satralizumab represents a potential new approach to treating neuromyelitis optica spectrum disorder (NMOSD), a rare, debilitating disease often misdiagnosed as multiple sclerosis (MS)… Click here…
September 12, 2019 | Beverly Hills, CA — Genentech, a member of the Roche Group, announced positive results from one of its phase III clinical…
The 46-year-old woman suddenly felt too weak to stand. She slowly lowered herself to her kitchen floor. She’d been vomiting for the past five weeks,…
KCBS Radio afternoon anchor and A2A founder Jeff Bell spotlights Victoria Jackson and the work she and her family are doing to find a cure for…
October 23, 2018 | Beverly Hills, CA — Chugai Pharmaceutical Co. announced positive results from one of its phase III clinical trials of satralizumab (SA237),…
September 25, 2018 | Beverly Hills, CA — The Guthy-Jackson Charitable Foundation (GJCF) congratulates Alexion Pharmaceuticals on their announcement of positive results from the PREVENT…
The Guthy-Jackson Charitable Foundation is pleased to welcome Christopher Clinton Conway in the newly-created position of Executive Director. Mr. Conway will serve as a highly-visible…
Paisley Forsell used to enjoy hiking, cliff jumping and competition body-building. She loves riding roller coasters. “I like adrenaline, I guess you’d say,” said the…
August 1, 2018, marks The Guthy-Jackson Charitable Foundation’s 10 Years Anniversary! In 2008, Ali Guthy, daughter of Victoria Jackson, founder & CEO of Victoria Jackson…
Rarity is a strength, not a weakness, when lessons learned from rare disease patients buoy research and development to find cures for more common diseases…….